← Open Payments lookup

YVETTE BALZANO: Open Payments

NPI 1134811482 · POINT PLEASANT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,267 in 138 payments from 14 companies in 2025. Trend: 2023 $357 · 2024 $1,258 · 2025 $2,267

Food & beverage: $2,155Education: $111
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.16$331
Lundbeck LLC19$310
Otsuka America Pharmaceutical, Inc.21$296
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$256
Tris Pharma Inc15$246
ABBVIE INC.22$237
Bausch Health US, LLC9$141
Takeda Pharmaceuticals U.S.A., Inc.6$104
Janssen Pharmaceuticals, Inc5$100
Vanda Pharmaceuticals Inc.5$87

Products named: REXULTI, CAPLYTA, Dyanavel XR, VRAYLAR, AUSTEDO XR, WELLBUTRIN, TRINTELLIX, FANAPT.

Industry payments across NJ — which companies pay providers there.